- Report
- January 2026
- 194 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 180 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 188 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 193 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- November 2025
- 196 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 183 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 197 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 193 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 190 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 191 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 195 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- August 2025
- 198 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 181 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- January 2026
- 180 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- February 2025
- 184 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- October 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- October 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more